Recurrent GBS with GD1a anti-ganglioside antibodies
Pınar Yalinay Dikmen,
A. Emre Oge,
Corresponding Author
Pınar Yalinay Dikmen
Departmentof Neurology, Acıbadem University School of Medicine
Pınar Yalinay Dikmen, Department of Neurology, Acıbadem University School of Medicine, Halit Ziya Uşaklıgil Caddesi. No : 1, Bakırkoy, Istanbul 34390, Turkey. Tel: +(90) 21241441 13; Fax: +(90) 21241451 70; E-mail: [email protected]Search for more papers by this authorA. Emre Oge
Department of Neurology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey
Search for more papers by this authorPınar Yalinay Dikmen,
A. Emre Oge,
Corresponding Author
Pınar Yalinay Dikmen
Departmentof Neurology, Acıbadem University School of Medicine
Pınar Yalinay Dikmen, Department of Neurology, Acıbadem University School of Medicine, Halit Ziya Uşaklıgil Caddesi. No : 1, Bakırkoy, Istanbul 34390, Turkey. Tel: +(90) 21241441 13; Fax: +(90) 21241451 70; E-mail: [email protected]Search for more papers by this authorA. Emre Oge
Department of Neurology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey
Search for more papers by this author
References
- American Association of Electrodiagnostic Medicine, Olney RK (1999). Guidelines in electrodiagnostic medicine. Consensus criteria for the diagnosis of partial conduction block. Muscle Nerve Suppl 8: S225–S229.
- Capasso M, Caporale CM, Pomilio F, Gandolfi P, Lugaresi A, Uncini A (2003). Acute motor conduction block neuropathy. Another Guillain-Barré syndrome variant. Neurology 61: 617–622.
- Combes A, Goulon M (1992). Recurrence of Guillain-Barré syndrome. Ann Med Interne (Paris) 143: 515–518.
- Das A, Kalita J, Misra UK (2004). Recurrent Guillain-Barré syndrome. Electromyogr Clin Neurophysiol 44: 95–102.
- Grand’Maison F, Feasby TE, Hahn AF, Koopman WJ (1992) Recurrent Guillain-Barré syndrome. Clinical and laboratory features. Brain 115: 1093–1106.
- Kaida K, Morita D, Kanzaki M, Kamaruka K, Motoyoski K, Hirakawa M, Kusunoki S (2004). Ganglioside complexes as new target antigens in Guillain-Barré syndrome. Ann Neurol 56: 567–571.
- Kawada Y, Fujita N, Yuki N, Ohashi T, Ohnishi Y (1992). Acute relapsing Guillain-Barré syndrome after 5 and 7 years asymptomatic intervals. Rinsho Shinkeigaku 32: 187–190.
- Kuitwaard K, Koningveld VR, Ruts L, Jacobs BC, van Doorn PA (2009). Recurrent Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 80: 56–59.
- Kusunoki S, Chiba A, Kon K, Ando S, Arisawa K, Tate A, Kanazawa I (1994). N-acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barré syndrome. Ann Neurol 35: 570–576.
- Martic V, Lepic T (2007). Recurrence of childhood Guillain-Barré syndrome after a long asymptomatic interval: a case report. J Clin Neuromuscul Dis 9: 256–261.
- Taly AB, Grupta SK, Anisya V, Shankar SK, Rao S, Das KB, Nagaraja D, Swamy HS (1995). Recurrent Guillain-Barré syndrome: a clinical, electrophysiological and morphological study. J Assoc Physicians India 43: 249–252.
- Uncini A, Yuki N (2009). Electrophysiologic and immunopathologic correlates in Guillain-Barré syndrome subtypes. Expert Rev Neurother 9: 869–884.
- Yuki N, Odada M (2005). Ganglioside mimicry as a cause of Guillain-Barré syndrome. Curr Opin Neurol 18: 557–561.
- Wijdicks EF, Ropper AH (1990). Acute relapsing Guillain-Barré syndrome after long asymptomatic intervals. Arch Neurol 47: 82–84.
Citing Literature
